Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension

被引:35
作者
Feng, Fei-Fei [1 ]
Zhang, Dian-Rui [1 ]
Tian, Ke-Li [2 ]
Lou, Hai-Yan [3 ]
Qi, Xiao-Li [2 ]
Wang, Yan-Cai [1 ]
Duan, Cun-Xian [1 ]
Jia, Le-Jiao [1 ]
Wang, Fei-Hu [1 ]
Liu, Yue [1 ]
Zhang, Qiang [4 ]
机构
[1] Shandong Univ, Dept Pharmaceut, Coll Pharm, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Inst Biochem & Mol Biol, Sch Med, Jinan 250012, Shandong, Peoples R China
[3] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250012, Shandong, Peoples R China
[4] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
关键词
Oridonin; nanosuspension; MCF-7; cells; apoptosis; LIPID NANOPARTICLES; BCL-2; DRUGS;
D O I
10.3109/10717544.2010.536271
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The mechanism for anti-tumor activity of oridonin (ORI) nanosuspension, prepared by the high pressure homogenization method, was studied using MCF-7 human breast carcinoma cells in vitro. MTT assay, observation of morphologic changes, flow cytometric analysis, and western blot analysis indicated that ORI nanosuspension could significantly intensify the in vitro anti-tumor activity to MCF-7 cells, as compared with ORI solution. Furthermore, ORI nanosuspension induced G(2)/M stage proliferation arrest and apoptosis in MCF-7 cells depending on its concentration. In addition, western blot analysis indicated that the pro-caspase-3 protein was not cleaved into the activated form and the expression of anti-apoptotic Bcl-2 protein decreased, on the contrary, the expression of pro-apoptotic Bax protein increased in a dose-dependent manner in ORI nanosuspension-treated cells. These observations indicated that the anti-tumor activity of ORI nanosuspension was intensified by cell-cycle arrest and apoptosis induction.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 18 条
[1]
Regulation of p53 stability and activity in response to genotoxic stress [J].
Colman, MS ;
Afshari, CA ;
Barrett, JC .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) :179-188
[2]
P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells [J].
Cui, Qiao ;
Yu, Jing-hua ;
Wu, Jin-nan ;
Tashiro, Shin-ichi ;
Onodera, Satoshi ;
Minami, Mutsuhiko ;
Ikejima, Takashi .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (07) :1057-1066
[3]
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles [J].
Date, Abhijit A. ;
Joshi, Medha D. ;
Patravale, Vandana B. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :505-521
[4]
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach [J].
des Rieux, Anne ;
Fievez, Virginie ;
Garinot, Marie ;
Schneider, Yves-Jacques ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (01) :1-27
[5]
Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis [J].
Engblom, P ;
Pulkkinen, JO ;
Rantanen, V ;
Hirvonen, H ;
Kulmala, J ;
Grènman, R ;
Grènman, S .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) :284-288
[6]
Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions [J].
Gao, Lei ;
Zhang, Dianrui ;
Chen, Minghui ;
Duan, Cunxian ;
Dai, Wenting ;
Jia, Lejiao ;
Zhao, Wenfa .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) :321-327
[7]
Ikezoe T, 2003, INT J ONCOL, V23, P1187
[8]
Nanosizing - Oral formulation development and biopharmaceutical evaluation [J].
Kesisoglou, Filippos ;
Panmai, Santipharp ;
Wu, Yunhui .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :631-644
[9]
Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2 [J].
Liang, Y ;
Nylander, KD ;
Yan, CH ;
Schor, NF .
MOLECULAR PHARMACOLOGY, 2002, 61 (01) :142-149
[10]
Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196